Results 51 to 60 of about 2,210,428 (254)

Lawn Mower Versus Left Ventricular Assist Device

open access: yesJACC: Case Reports, 2020
A 77-year-old man with history of ischemic cardiomyopathy and left ventricular assist device (LVAD) presented with abdominal pain after a lawn mower accident.
Vishal N. Rao, MD, MPH   +8 more
doaj   +1 more source

Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic

open access: yesAdvanced Robotics Research, EarlyView.
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang   +5 more
wiley   +1 more source

Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device [PDF]

open access: yes, 2013
OBJECTIVE: Current pulsatile ventricular assist devices operate asynchronous with the left ventricle in fixed-rate or fill-to-empty modes because electrocardiogram-triggered modes have been abandoned. We hypothesize that varying the ejection delay in the
Amacher, Raffael   +8 more
core   +1 more source

Treating myocardial stunning randomly, with either propofol or isoflurane following transient coronary occlusion and reperfusion in pigs

open access: yesAnnals of Cardiac Anaesthesia, 2009
Propofol and isoflurane may be used during fast track anesthesia for off-pump bypass, where transient ischemia is common. The purpose of this study was to compare the effects of propofol vs isoflurane in a porcine model of acute coronary occlusion ...
Urdaneta Felipe   +3 more
doaj  

Innate Immunocompetent hiPSC‐Derived Neurospheroids Capture Early CNS Responses to rAAV

open access: yesAdvanced Science, EarlyView.
Knowledge of human CNS immune responses to AAV‐based gene therapies remains limited due to the lack of immune‐competent human models. Here, a hiPSC‐derived 3D neuroimmune platform integrating neurospheroids and microglia is established using stirred‐tank bioreactors.
Catarina M. Gomes   +14 more
wiley   +1 more source

Optimal timing of cardiac transplantation after ventricular assist device implantation [PDF]

open access: yes, 2004
ObjectiveWe sought to determine the influence of the interval from ventricular assist device implantation to cardiac transplantation on end-organ function and posttransplantation survival.MethodsUnited Network for Organ Sharing data on 2692 heart ...
Tsao, Lana   +4 more
core   +1 more source

Postoperative care of 14 patients with left ventricular assist devices: a case series

open access: yesJournal of International Medical Research
A left ventricular assist device is a mechanical device that is surgically implanted in the heart to partially or completely replace the function of the heart.
Shenmin Wan   +3 more
doaj   +1 more source

Conservative Management of LVAD-Associated Ventricular Pseudoaneurysm

open access: yesMethodist DeBakey Cardiovascular Journal
Left ventricular assist devices (LVAD) are surgically implanted mechanical support devices utilized with increasing frequency as a bridge to myocardial recovery, destination therapy, and heart transplantation.
Marvin Kajy   +4 more
doaj   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Mechanical recovery plug for left ventricular assist device explantation

open access: yes, 2022
Myocardial recovery occurs in approximately 5% of left ventricular assist device recipients. In selected patients, it is possible to electively perform left ventricular assist device explantation after accurate myocardial function recovery assessment ...
Pacini D.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy